All rituximab articles
-
NewsLongest known SARS-CoV-2 infection of 613 days led to unique highly mutated variant
New research to be presented at next week’s ESCMID Global Congress highlights the risk of new immune-evasive SARS-CoV-2 variants emerging in immunocompromised patients.
-
NewsB cell deficient patients gain protective T cell immunity after SARS-CoV-2 vaccination, infection
Researchers found that vaccinated B cell-deficient individuals had significantly reduced risk of moderate and severe disease in comparison to those who were not vaccinated, despite an absence of anti-spike antibody responses.
